These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1171 related articles for article (PubMed ID: 7496598)
1. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours. Takahashi H; Saitoh K; Kishi H; Parsons PG Virchows Arch; 1995; 427(3):283-8. PubMed ID: 7496598 [TBL] [Abstract][Full Text] [Related]
2. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. Giehl KA; Nägele U; Volkenandt M; Berking C J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848 [TBL] [Abstract][Full Text] [Related]
3. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Ohashi A; Funasaka Y; Ueda M; Ichihashi M Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066 [TBL] [Abstract][Full Text] [Related]
4. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526 [TBL] [Abstract][Full Text] [Related]
5. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin. Saitoh K; Takahashi H; Sawada N; Parsons PG J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252 [TBL] [Abstract][Full Text] [Related]
6. Micro-anatomy related antigen expression in melanocytic lesions. Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983 [TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Montone KT; van Belle P; Elenitsas R; Elder DE Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959 [TBL] [Abstract][Full Text] [Related]
8. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. Bokemeyer C; Kuczyk MA; Dunn T; Serth J; Hartmann K; Jonasson J; Pietsch T; Jonas U; Schmoll HJ J Cancer Res Clin Oncol; 1996; 122(5):301-6. PubMed ID: 8609154 [TBL] [Abstract][Full Text] [Related]
9. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075 [TBL] [Abstract][Full Text] [Related]
10. Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R. Luo D; Chen H; Searles G; Jimbow K Melanoma Res; 1995 Oct; 5(5):303-9. PubMed ID: 8541720 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of germinal center-associated nuclear protein (GANP) is associated with malignant transformation of melanocytes. Kageshita T; Kuwahara K; Oka M; Ma D; Ono T; Sakaguchi N J Dermatol Sci; 2006 Apr; 42(1):55-63. PubMed ID: 16431081 [TBL] [Abstract][Full Text] [Related]
12. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. Randall VA; Jenner TJ; Hibberts NA; De Oliveira IO; Vafaee T J Endocrinol; 2008 Apr; 197(1):11-23. PubMed ID: 18372228 [TBL] [Abstract][Full Text] [Related]
13. The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Esposito I; Kleeff J; Bischoff SC; Fischer L; Collecchi P; Iorio M; Bevilacqua G; Büchler MW; Friess H Lab Invest; 2002 Nov; 82(11):1481-92. PubMed ID: 12429808 [TBL] [Abstract][Full Text] [Related]
14. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Petersson S; Shubbar E; Enerbäck L; Enerbäck C Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263 [TBL] [Abstract][Full Text] [Related]
15. Implication of stem cell factor in the proliferation of choroidal melanocytes. Mouriaux F; Chahud F; Maurage CA; Malecaze F; Labalette P Exp Eye Res; 2001 Aug; 73(2):151-7. PubMed ID: 11446765 [TBL] [Abstract][Full Text] [Related]
16. C-kit expression in canine mucosal melanomas. Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314 [TBL] [Abstract][Full Text] [Related]
17. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. Krengel S; Grotelüschen F; Bartsch S; Tronnier M J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278 [TBL] [Abstract][Full Text] [Related]
18. Topography of Protein Kinase C βII in Benign and Malignant Melanocytic Lesions. Krasagakis K; Tsentelierou E; Chlouverakis G; Stathopoulos EN Int J Surg Pathol; 2017 Sep; 25(6):497-501. PubMed ID: 28436290 [TBL] [Abstract][Full Text] [Related]
19. Autocrine/Paracrine Loop Between SCF Annese T; Tamma R; Bozza M; Zito A; Ribatti D Front Immunol; 2022; 13():794974. PubMed ID: 35140718 [TBL] [Abstract][Full Text] [Related]
20. Proliferative activity of primary cutaneous melanocytic tumours. Kuwata T; Kitagawa M; Kasuga T Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]